Top Trending Healthcare and Healthcare IT News: October 2020

Friday 9 October 2020

Global Diagnostic Imaging Services Market 2019-2023 Research Analysis by CAGR, Production, Growth and Forecast

Market Highlights

The Global diagnostic imaging market is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period. Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region. Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

Key Players

Some of the prominent players in the global diagnostic imaging services market are Center for Diagnostic Imaging (CDI), Medquest Associates Inc./Novant Health, Simonmed/Dignity Health, Touchstone Imaging, Alliance Medical, Medica Group, Sonic Healthcare, Global Diagnostics, Consensys Imaging Service, Inc., Progressive Radiology, Concord Medical Services Holdings Limited, Alliance Healthcare Services, InHealth Group and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Diabetes Monitors Market 2020- Trends, Size, share and Forecast

Diabetes Monitors Market Overview

Diabetes monitors automatically track blood glucose levels, also called blood sugar, any time a patient needs. One can easily see glucose level anytime at a glance. The users can also review how their glucose level in the body changes over a few days or even a few hours to see the patterns. Diabetes monitoring in real time can help people make more informed decisions about their diet and other things throughout the day, week, or month and can balance physical activity, food, and medicines without having to rely on costly lab tests.

Latest Free Sample Copy Available Here !! https://www.marketresearchfuture.com/sample_request/4781

The blood sugar levels of everyone change during the day, and particularly after eating, but these changes are important to monitor for diabetic people, as their bodies do not control blood sugar on their own. However, the pancreas normally produces insulin for individuals without diabetes to keep conditions in check. Diabetes devices take up to five minutes to calculate and individuals can set alerts to warn them if their blood sugar levels are alarmingly high or low.

The increasing occurrence of diabetes in low and middle class families residing in different countries seems to be driven by a dietary change, urbanisation, and rapidly unhealthy lifestyles. Many other factors including rising technical advances, research support for diabetes diagnosis and care, growing government approval, and increased global diabetes rate also drive growth in the future. It is projected that the demand for diabetes monitoring solutions is expected to expand at an 8.3 per cent CAGR from 2017 to 2023.

Diabetes Monitors Market Segmentation

The worldwide diabetes monitoring market is bifurcated by type, sample, component and end-users. The market is subdivided, depending on the sample, into urine samples, sweat samples, blood samples, and others. The global diabetes monitoring is categorized by type into continuous glucose monitors, point-sample test-based glucose monitors, and enzyme-free glucose-based sensor monitoring systems. the former is further subdivided into, and CGM based on reusable sensors and disposable sensor based CGM. The market is categorized as per the components as glucose check strips, lancet, and sensors. Based on end users, the global market for diabetes monitoring is segmented into diagnostic clinics, hospitals, and homes.

Diabetes Monitors Market Regional Overview

Due to the size of the patient group, a very well-developed infrastructure, higher healthcare spending, and the existence of major players, the Americas dominates the diabetes monitoring market. Europe is in second place in the market for diabetes monitors. It is anticipated that the funding provided for research & development by public authorities together with an excellently-developed tech environment would drive the demand for diabetes monitors in the European region. During the forecast period, the Asia Pacific region is expected to become the fastest growing market. However, due to the presence of weak and underdeveloped countries, particularly in the African market, the Middle East and Africa holds the smallest share in the global market.

Industry News

So far, the NHS Long Term Program has delivered diabetes monitors to thousands of people around the world, helping about 30 000 people with a type I diabetes. The sensors, that are the size of a £2 coin and made to wear on the chest, ensure that people with type I don't have to conduct several uncomfortable finger-prick tests to track their blood sugar.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Global Conjugate Vaccines Market Research Report- trends, news updates, forecast

The global conjugate vaccines market is analyzed in detail in the latest market research report from Market Research Future (MRFR). The report studies the global conjugate vaccines market’s historical growth trajectory in order to provide pointers as to the major drivers and restraints affecting the market’s growth prospects and derive market growth markers that can indicate the market’s future growth trajectory over the forecast period from 2018 to 2027. The global conjugate vaccines market is expected to exhibit a robust 14.5% CAGR over the forecast period, according to MRFR.

Get Free Sample Copy !! https://www.marketresearchfuture.com/sample_request/1107

Conjugate vaccines are vaccines containing two antigens, one strong and one weak. The stronger antigen is generally made from proteins and is attached to a weaker polysaccharide antigen to form conjugate vaccines. Conjugate vaccines are used to counter diseases whose associated pathogens do not elicit a significant response from the human immune system on their own. As a result, a stronger antigen is attached to the weaker pathogen to make it more prominent and to elicit a stronger response from the immune system. The first conjugate vaccine was developed in response to the outbreak of meningitis, which still remains among the top targeted diseases in the conjugate vaccines market.

The growing government support for mass-scale vaccinations for disease eradication is likely to remain the prime driver for the global conjugate vaccines market over the forecast period. Vaccination has taken on a key role in eliminating diseases such as meningitis, which can become a serious health problem given the right conditions. The growing support for further advancement in vaccine research and development is also likely to be a major driver for the global conjugate vaccines market over the forecast period. Considerable growth in vaccine development efforts from major market players is likely to be a major driver for the conjugate vaccines market over the forecast period.

Regional Analysis:

The global conjugate vaccines market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global conjugate vaccines market due to the growing demand for wide-scale disease eradication through vaccines and the growing vaccine research environment in advanced countries such as the U.S. and Canada. The growing government support to vaccination and vaccine development in this region, along with the presence of a strong and advanced biotechnology sector in the region, is also likely to be a major driver for the conjugate vaccines market over the forecast period.

Europe follows the Americas region in terms of its share in the global conjugate vaccines market and is likely to remain in a leading position through the forecast period due to the growing awareness about vaccines in Europe and the growing demand for developing cost-efficient, effective formulations of vaccines. The strong presence of the medical biotechnology sector in the region is also likely to be a major driver for the conjugate vaccines market in Europe.

Asia Pacific follows Europe in the global conjugate vaccines market and is likely to hold a reasonable share in the global market over the forecast period due to the growing awareness about the importance of vaccination in countries such as China and India. The growing population of this region is likely to drive the conjugate vaccines market in Asia Pacific over the forecast period.

Competitive Analysis:

Leading players in the global conjugate vaccine market include GSK plc, Fablife, Sanofi Pasteur SA, Sinovac Biotech Ltd., GreenSignal Bio Pharma Limited, Bavarian Nordic, Taj Pharmaceuticals Limited, IDT Biologics, Pfizer, SutroVax Inc., and Merck & Co. Inc.

Industry Updates:

In March 2019, Pfizer initiated three phase III trials on its new 20-valent pneumococcal conjugate vaccine.

Segmentation:

The global conjugate vaccine market is segmented on the basis of type, indication, end user, and region.

On the basis of type, the global conjugate vaccine market is segmented into haemophilus B, monovalent, multivalent, and others.

On the basis of indication, the conjugate vaccines market is segmented into influenza, pneumococcal, meningococcal, and others. Influenza dominates the global conjugate vaccines market with a 35% share, however, pneumococcal and meningococcal vaccines are also likely to take up a considerable share of the global conjugate vaccines market over the forecast period.

On the basis of end users, the market is segmented into pediatrics and adults.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Industry Trends On Aromatherapy Market Size, share and Report

Surgeries and medicines made from chemicals are not the remedies for every medical problem. Sometimes, aromatherapy can heal patients in miraculous ways if patients can use aromatic plant oils (including essential oils and other aroma compounds) in the correct manner. Therefore, the market for aromatherapy is rising due to various factors that include the growing lifestyle industry, large number of people opting for aromatherapy and non-invasive nature of aromatherapy. Aromatherapy via essential oils can not only combat cold and breathing disorders, it can also enhance the immunity (and resistance against diseases) of the human body. Aromatherapy is also the remedy for problems that are caused by the modern lifestyle. The market restraints that are likely to slow down the growth of the aromatherapy market include increasing stringency of regulations such as indications which a brand has to provide. For example, the brand needs to mention the category the essential oil falls in.

Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/3241

Market Research Future (MRFR) has published a research report about global aromatherapy market. The theory of this report anticipates 6.18% CAGR (Compound Annual Growth Rate) between 2017 and 2023. In terms of cash, the market growth is expected to reach the US $ 4.3 bn by the end of the forecast period. This report analyzes the market structure with the forecast for six years, factors affecting market growth, on the basis of porters five force analysis, price analysis, and supply chain analysis. It also lists the key players and explores their business strategies. Market developments that are competitive in nature include the development of new treatments, joint ventures, mergers and acquisitions, and strategic alliances.

The global aromatherapy market has been segmented on the basis of the product. The product-based segmentation covers application, essential oils, equipment, therapeutic application and lastly region. The application segment has been sub-segmented into inhalation, tropical, and aerial diffusion. Based on essential oils, the market segmentation comprises of citrus, floral, green/vegetative, herbaceous/camphoraceous, & spicy and others. The equipment segment has been segmented into heat diffuser, nebulizer diffuser, and ultrasonic diffuser. On the basis of therapeutic application, the market has been segmented into pain management, relaxation and sleep, skin and hair care, and other remedies.

The regional segmentation of the global Aromatherapy Market covers North America, Europe, Asia Pacific, and Middle East & Africa (MEA). The biggest regional market in the global aromatherapy market in North America, and the backbone of this market is the revenue from the United States of America (USA). Due high density of population and high per capita income, the USA is a big market by default. The only restraint in this region is ambiguity and uncertainty of the therapeutic potential of aromatherapy. The second largest and fastest growing market for aromatherapy is Europe. In Europe, France is the biggest market for aromatherapy due to a tradition of aromatics whereas Italy is the second largest market. Majority of the biggest players of the global aromatherapy market are also based in North America and Europe. This is also another reason for these two continents emerging as the two biggest regional markets. Asia Pacific region is witnessing a steady growth of the aromatherapy market with China being the biggest market due to the high population while India is the second largest market here. As China and India have traditions of aromatherapy, in these countries, the market is high despite lower per capita income compared to developed regions. In the MEA region, Saudi Arabia, and United Arab Emirates (UAE) are very lucrative markets due to their greater wealth and the greater expansion of tourism in these regions. Among African countries, Algeria, Egypt, and South Africa. Due to poor income and low expenditure on public healthcare, the market of remaining Africa is low.

Key Players

The key players in global aromatherapy market include Air Aroma (USA), Nu Skin (USA), Muji (Japan), Tree of Life (made by Jaroma), Young Living (USA), Zija International (China), dōTERRA (USA), NOW Foods (USA), and Neal’s Yard Remedies (United Kingdom).

Latest Industry News

· Olfinity, an intelligent air system is set to bring air purification, air quality assessment, and controlled aromatherapy together in a series of products. These products are meant to improve indoor health and wellness. The Olfinity series of products includes an air monitor, air purifier, and aromatherapy diffuser.

· Entering the “wellness market,” popular retailer Anthropologie is launching a new range of products that includes aromatherapy and essential oils, books and stationery, coffee and teas, crystals, fitness products, hair and skin care items, and supplements.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Worldwide Analysis On AI in drug discovery Market Forecast From 2019 to 2025

The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes.

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery.

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market.

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology : Machine Learning, Deep Learning, and others.

By Indication : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions : Americas, Europe, Asia Pacific, and Rest-of-the-World.

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI applications in drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.

https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Major Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others.

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com